Shares of CNS Pharmaceuticals Inc. (CNSP) are rising over 7% in pre-market today, after the company announced that it has filed an application with the U.S. FDA to receive Orphan Drug Designation or ODD for its lead product Berubicin.
from RTT - Before the Bell https://ift.tt/3cG80Qn
via IFTTT
No comments:
Post a Comment